This may have potentially prompted segregation testing of the LARS2 variants and diagnosed Perrault syndrome years before the onset of premature ovarian insufficiency in the proband and would have been helpful for improving overall management of progressive co-morbidities in both individuals. The gene discussed is LARS2; the disease is premature menopause.